Ranakishor Pelluri

Guntur, AP, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Association Between the Use of Gabapentinoids and Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis.

Association Between the Use of Gabapentinoids and Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis.

Journal: Current therapeutic research, clinical and experimental

Published: April 10, 2026

Palliative Benefits of Zoledronic Acid on Pain, Functioning and Quality of Life in Metastatic Cancers: A Cohort Study.

Palliative Benefits of Zoledronic Acid on Pain, Functioning and Quality of Life in Metastatic Cancers: A Cohort Study.

Journal: Journal of palliative care

Published: September 29, 2025

PDE5 Inhibitors as Modulators of Alzheimer's-Associated Inflammation and Oxidative Stress: A Meta-Analytical Assessment of Preclinical Studies.

PDE5 Inhibitors as Modulators of Alzheimer's-Associated Inflammation and Oxidative Stress: A Meta-Analytical Assessment of Preclinical Studies.

Journal: Molecular neurobiology

Published: July 08, 2025

Prevalence of Hypocalcemia in Pediatrics With Lower Respiratory Tract Infections.

Prevalence of Hypocalcemia in Pediatrics With Lower Respiratory Tract Infections.

Journal: Clinical pediatrics

Published: February 26, 2025

Effect of platelet-rich plasma versus placebo or corticosteroid for knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials.

Effect of platelet-rich plasma versus placebo or corticosteroid for knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials.

Journal: Journal of clinical orthopaedics and trauma

Published: September 16, 2024

Unveiling the mTOR pathway modulation by SGLT2 inhibitors: a novel approach to Alzheimer's disease in type 2 diabetes.

Unveiling the mTOR pathway modulation by SGLT2 inhibitors: a novel approach to Alzheimer's disease in type 2 diabetes.

Journal: Metabolic brain disease

Published: August 28, 2024

Effect of Teneligliptin 20 mg Twice Daily on Glucagon-Like Peptide-1 Levels and Its Influence on Non-Glycemic Components in Non-Diabetic Obese Individuals.

Effect of Teneligliptin 20 mg Twice Daily on Glucagon-Like Peptide-1 Levels and Its Influence on Non-Glycemic Components in Non-Diabetic Obese Individuals.

Journal: Metabolic syndrome and related disorders

Published: January 02, 2024

Association between physical activity knowledge and attitude on diabetes among normal weight and overweight/obese type-2 diabetic patients: a rural community-based cross-sectional study.

Association between physical activity knowledge and attitude on diabetes among normal weight and overweight/obese type-2 diabetic patients: a rural community-based cross-sectional study.

Journal: African health sciences

Published: August 29, 2022

Systematic review and meta-analysis of teneligliptin for treatment of type 2 diabetes.

Systematic review and meta-analysis of teneligliptin for treatment of type 2 diabetes.

Journal: Journal of endocrinological investigation

Published: August 25, 2022

The role of body mass index or metabolic syndrome components causing depression in women: An observation from weight reduction clinical trial.

The role of body mass index or metabolic syndrome components causing depression in women: An observation from weight reduction clinical trial.

Journal: Journal of clinical pharmacy and therapeutics

Published: May 20, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026